138 related articles for article (PubMed ID: 17489582)
41. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR; Tam SP; Lu X
Endocrinology; 2008 Oct; 149(10):4857-70. PubMed ID: 18599548
[TBL] [Abstract][Full Text] [Related]
42. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
43. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
44. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site.
Salvatori L; Pallante P; Ravenna L; Chinzari P; Frati L; Russo MA; Petrangeli E
Oncogene; 2003 Jul; 22(31):4875-81. PubMed ID: 12894229
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of a novel series of furans: ligands selective for estrogen receptor alpha.
Mortensen DS; Rodriguez AL; Carlson KE; Sun J; Katzenellenbogen BS; Katzenellenbogen JA
J Med Chem; 2001 Nov; 44(23):3838-48. PubMed ID: 11689070
[TBL] [Abstract][Full Text] [Related]
46. Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism.
Abdelhamid R; Luo J; Vandevrede L; Kundu I; Michalsen B; Litosh VA; Schiefer IT; Gherezghiher T; Yao P; Qin Z; Thatcher GR
ACS Chem Neurosci; 2011 May; 2(5):256-268. PubMed ID: 21731800
[TBL] [Abstract][Full Text] [Related]
47. Androstene-3,5-dienes as ER-beta selective SERMs.
Blizzard TA; Gude C; Morgan JD; Chan W; Birzin ET; Mojena M; Tudela C; Chen F; Knecht K; Su Q; Kraker B; Mosley RT; Holmes MA; Rohrer SP; Hammond ML
Bioorg Med Chem Lett; 2007 Nov; 17(22):6295-8. PubMed ID: 17890084
[TBL] [Abstract][Full Text] [Related]
48. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
[TBL] [Abstract][Full Text] [Related]
49. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
50. The 2.0 A crystal structure of the ERalpha ligand-binding domain complexed with lasofoxifene.
Vajdos FF; Hoth LR; Geoghegan KF; Simons SP; LeMotte PK; Danley DE; Ammirati MJ; Pandit J
Protein Sci; 2007 May; 16(5):897-905. PubMed ID: 17456742
[TBL] [Abstract][Full Text] [Related]
51. Investigations on the effects of basic side chains on the hormonal profile of (4R,5S)/(4S,5R)-4,5-bis(4-hydroxyphenyl)-2-imidazolines.
von Rauch M; Busch S; Gust R
J Med Chem; 2005 Jan; 48(2):466-74. PubMed ID: 15658860
[TBL] [Abstract][Full Text] [Related]
52. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
53. Deoxybenzoins are novel potent selective estrogen receptor modulators.
Papoutsi Z; Kassi E; Fokialakis N; Mitakou S; Lambrinidis G; Mikros E; Moutsatsou P
Steroids; 2007 Sep; 72(9-10):693-704. PubMed ID: 17659312
[TBL] [Abstract][Full Text] [Related]
54. Synthesis, biological evaluation, structural-activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators.
Barrett I; Meegan MJ; Hughes RB; Carr M; Knox AJ; Artemenko N; Golfis G; Zisterer DM; Lloyd DG
Bioorg Med Chem; 2008 Nov; 16(21):9554-73. PubMed ID: 18835176
[TBL] [Abstract][Full Text] [Related]
55. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.
Burendahl S; Danciulescu C; Nilsson L
Proteins; 2009 Dec; 77(4):842-56. PubMed ID: 19626711
[TBL] [Abstract][Full Text] [Related]
56. Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor α Ligand Binding Domain.
Arao Y; Korach KS
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366023
[TBL] [Abstract][Full Text] [Related]
57. Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test.
Walf AA; Rhodes ME; Frye CA
Pharmacol Biochem Behav; 2004 Jul; 78(3):523-9. PubMed ID: 15251261
[TBL] [Abstract][Full Text] [Related]
58. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold.
Richardson TI; Norman BH; Lugar CW; Jones SA; Wang Y; Durbin JD; Krishnan V; Dodge JA
Bioorg Med Chem Lett; 2007 Jul; 17(13):3570-4. PubMed ID: 17485205
[TBL] [Abstract][Full Text] [Related]
59. Ligand-selective interdomain conformations of estrogen receptor-alpha.
Padron A; Li L; Kofoed EM; Schaufele F
Mol Endocrinol; 2007 Jan; 21(1):49-61. PubMed ID: 17008385
[TBL] [Abstract][Full Text] [Related]
60. Binding capacity of ER-α ligands and SERMs: comparison of the human, dog and cat.
Toniti W; Suthiyotha N; Puchadapirom P; Jenwitheesuk E
Asian Pac J Cancer Prev; 2011; 12(11):2875-9. PubMed ID: 22393957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
